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The genus Enterovirus,  a member of the Picornavirus family, are RNA viruses that can cause
poliomyelitis, hand-food-mouth disease, viral meningitis or meningoencephalitis, viral
myocarditis and so on. MicroRNAs are a class of highly conserved, small noncoding RNAs
recognized as important regulators of gene expression. Recent studies found that MicroRNAs
play  a signiﬁcant role in the infection of Enterovirus, such as enterovirus 71, coxsackievirus
B3  and other Enterovirus. Enteroviral infection can alter the expression of cellular MicroR-
NAs, and cellular MicroRNAs can modulate viral pathogenesis and replication by regulatingEnterovirus
Infection
the  expression level of viral or host’s genes. Herein, this review summarizes the role of
MicroRNAs in enteroviral infection.
© 2015 Elsevier Editora Ltda. All rights reserved.Introduction
MiRNAs are a class of highly conserved, small noncoding RNAs
molecules, which contain 18- to 25- nucleotides (nt) in almost
all eukaryotes. MiRNAs regulate gene expression at the post-
transcriptional level, inﬂuence important physiological and
pathological processes.1 For example, miR-375 can promote
beta-pancreatic differentiation in human induced pluripotent
stem cells.2 In some tumor diseases, miRNAs hold a pivotal
regulatory role. MiR-15a and miR-16 can induce the devel-
opment of multiple myeloma.3 MiRNAs act on mRNAs by
either translation inhibition or mRNA  degradation, depend-
ing on the extent of complementarity between target mRNA
and miRNA sequence. There are two main mechanisms:
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mRNA results in translation inhibition,4,5 and perfect
sequence complementarity leads to mRNA  cleavage.6 The
mechanism may be inﬂuenced by parameters such as the
degree of sequence homology,1 target site multiplicity,7 the
free energy of binding, target site secondary structure,8 and
location of mRNA.9 MiRNAs can down-regulate the expres-
sion of their target mRNAs predominantly by binding to 3′
untranslated region (3′ UTR) of 28 mRNA.9,10 Recent evidences
showed that miRNA can also bind to the 5′ UTR11 or coding
regions12 of the target gene to regulate gene expression. More-ng Center for Disease Control and Prevention, Zhenjiang 212003,
over, one miRNA can target multiple mRNAs  and one mRNA
can be controlled by multiple miRNAs.9,10,13 In conclusion,
miRNAs play an important role in cell development, apopto-
sis, proliferation, and signal transduction.14 Additionally, fat
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nd cholesterol metabolism, nerve development, hormone
ecretion, and immune response may also be affected by
iRNAs.15,16
The genus Enterovirus (EV), one group of the picornavirus
amily, has the following species according to the International
ommittee on Taxonomy of Viruses: EV-A, which contains
V71 and several Coxsackievirus group A (CVA) viruses; EV-
 (Coxsackievirus group B (CVB) viruses, CVA9, echoviruses
nd few other EV); EV-C (polioviruses (PV) 1–3, several CVA
nd few other EV); EV-D (EV-D68, EV-D111, EV 70 and EV74);
V-E, EV-F, EV-G, EV-H, EV-J, and the rhinoviruses (HRV-A,
RV-B, HRV-C). The polyprotein of EV consists of P1, P2,
nd P3 regions, which encode structural proteins (VP4-VP1)
nd non-structural proteins (2A, 2B, 2C and 3A, 3B, 3C, 3D)
espectively. EV infected millions of people worldwide in
ecent years, resulting in severe complication: HFMD, acute
emorrhagic conjunctivitis, myocarditis, aseptic meningitis,
evere neonatal sepsis-like disease, acute ﬂaccid paraly-
is, and so on.17 The best known members of the genus
nterovirus are PV, EV7, CV, and echovirus. PV is spread via the
ecal–oral route and rarely invades the central nervous sys-
em (CNS). However, in the rare instances when PV invades
he CNS, the resulting damage to motor neurons is strik-
ng and often permanent. EV71 and CVA16 are common
tiological agents of HFMD.18 As a neurotropic enterovirus,
V71 can violate the patient’s nervous system and lead to
evere symptoms and even to death.19,20 CV is classiﬁed
nto two types, CVA and CVB. CVAs are usually prevalent
n summer and mainly cause herpetic angina, skin rash,
eningitis, paralytic polio lesions, fetal intrauterine infec-
ion, and suffocation during infection in pregnancy. Some of
VAs, such as CVA16, CVA4, CVA5, CVA9, CVA10, are causative
gents of HFMD as EV71. CVBs are the major pathogens
f human viral myocarditis that can result in severe car-
iac failure and dilated cardiomyopathy.21,22 Besides these,
choviruses 4 (E4), E16, and E30 are associated with type
 diabetes.23 E4, E6, E11, E13, and E30 are related to acute
eningitis/encephalitis,24,25 while E13 and E11 can cause non-
olio acute ﬂaccid paralysis.26
Accumulated evidence has demonstrated that there are
ntricate interactions between miRNAs and viruses. MiRNAs
an be induced and regulated by viruses. For instance, miR-101
ay serve as a potential biomarker in hepatocellular carci-
oma (HCC) patients because miR-101 is down-regulated in
epatitis B virus (HBV)-related HCC tissues.27 HBV X pro-
ein can inhibit miR-205 by hypermethylating of miR-205
romoter.28 Meanwhile, many  evidence has showed that cel-
ular miRNAs play a crucial role in regulating viral replication
nd pathogenesis in eukaryotes. For example, hsa-miR-29a
own-regulates the expression of HIV Nef protein and inter-
eres with HIV-I replication.29 MiR-198 can inhibit HIV-1 gene
xpression and replication in monocytes.30 Representatively,
iR-122 positively regulates HCV infection by increasing HCV
ranslation and genomic RNA stability through direct interac-
ions with the viral RNA genome.31–33 At the same time, many
esearchers have demonstrated that miRNAs play an impor-
ant role during EV infection. However, there are no summary
bout the role of miRNAs involved in enteroviral infection
et. Thus, this review attempts to provide recent advance-
ents about the role and machinery of miRNAs in enteroviral5;1 9(5):510–516 511
infection, in order to increase our understanding of enteroviral
pathogenesis.
The  related  investigations  of  miRNAs  and  EV71
Due to the virulent pathogenicity of EV71, many  researches
have been carried out to explore the role of miRNAs during
EV71 infection. It has been veriﬁed that circulating miRNAs
play an essential role in pathogen–host interactions. Disrup-
tion of miRNA biogenesis by knocking down  the DGCR8 gene,
an essential cofactor for miRNAs biogenesis, resulted in the
inability of EV71 to cause infection. The expression of many
key genes related to the innate antiviral immune response in
EV71 infected miRNAs depleted cells was signiﬁcantly higher
in comparison with control cells. It has been showed that
EV71 can utilize host miRNAs to mediate host immune sys-
tem enhancing infection.34 MiRNA can serve as a molecular
marker for the detection of enteroviral infections. Cui and col-
leagues found that the expression level of 64 miRNAs changed
over 2-fold in response to EV71 infection by deep sequencing
assay, and 42 of these 64 miRNAs were up-regulated and others
were down-regulated. Many of these miRNAs are associated
with metabolic process and neurological processes, apoptosis,
and immune response according to the result of gene ontology
analysis.35 Subsequently, by using a miRNA array, this team
reported that six miRNAs (miR-148a, miR-143, miR-324-3p,
miR-628-3p, miR-140-5p, and miR-362-3p) in serum could dis-
criminate patients with EV infections from healthy controls,
and three miRNAs (miR-545, miR-324-3p, miR-143) could dis-
tinguish EV71 from CVA16 infections.36 Collectively, miRNAs
are closely associated with enterovirual infection.
Some miRNAs can modulate the replication of EV71 by tar-
geting the viral genome directly. For example, Zheng et al.37
found that miRNA-296-5p was elevated in EV71-infected cells
by using a comprehensive miRNA proﬁling. They predicted by
bioinformatic analysis that human miR-296-5p can inhibit the
replication of EV71 by binding to the coding regions of VP3 and
VP1 proteins. It is predicted that miR-23b can target the con-
servative sequence of EV71 3′ UTR by biological software. Then
it is conﬁrmed that miR-23b can inhibit the replication of EV71
by targeting EV71 3′ UTR by luciferase reporter vector and miR-
23b mimics transfection.38 Yang et al.39 screened the miRNAs
that may target EV71 gene sequence by using online analy-
sis programs, then veriﬁed that miR373 and miR542-5p could
suppress the replication of EV71 virus through binding to the
5′-UTR gene.
There are also some miRNAs that modulate viral repli-
cation indirectly by targeting the mediator. Interferon
(IFN)-mediated pathway is a crucial part of the cellular
response against viral infection. Type III IFNs, which include
IFN-1, 2, and 3, mediate antiviral responses similar to Type
I IFNs.40 There are some miRNAs that modulate viral repli-
cation involved IFN. MiRNA-548 can enhance replication of
EV71 and vesicular stomatitis virus (VSV) by targeting the
3′UTR of IFN-1 and the levels of endogenous miRNA-548
41are down-regulated during viral infection. EV71-induced
miR-146a can suppress the expression of IRAK1 and TRAF6
which are two major elements in IFN production. Thus,
EV71-induced miR-146a can enhance viral pathogenesis by
i s . 2 0512  b r a z j i n f e c t d 
suppressing IFN production.42 Retinoic acid-inducible gene
I (RIG-I) is an intracellular RNA virus sensor that induces
type I interferon-mediated host-protective innate immunity
against viral infection. There is a novel positive regulator
of RIG-I signaling pathway related to miRNA and EV71.43
EV71-induced miR-526a positively regulates type I IFN pro-
duction and inhibits viral replication. The enhancement
of this antiviral immune response then derived from sup-
pressing cylindromatosis (CYLD) expression by miR-526a.
Remarkably, virus-induced miR-526a upregulation and CYLD
downregulation can be blocked by EV71 3C protein. Cells
with overexpressed miR-526a enhance the resistance to EV71
infection. In addition to this, Chang et al. investigated an
apoptosis-oriented approach by using mRNA-miRNA proﬁl-
ing and bioinformatic analysis. They predict and veriﬁed that
miR-146a and miR-370 could impact two major apoptosis-
associated signaling pathways by decreasing Son of sevenless
homolog 1 (SOS1) and growth arrest and DNA damage-
inducible protein 45  (GADD45) expression, respectively.
MiR-146a and miR-370 coordinate to trigger cell apoptosis in
EV71 infection.44 EIF4E is the cap-dependent translation ini-
tiation factor to shut off host protein synthesis. MiR-141 can
facilitate EV infection including EV71, PV3 and CVB3 by tar-
geting 3′-UTR of eIF4E.45 EV71 down-regulated the expression
of miR-27a signiﬁcantly. Further study showed that miR-27a
could inhibit EV71 replication by targeting epidermal growth
factor receptor (EGFR).46
Moreover, to explain the neurological pathogenesis of EV71,
Xu et al. did whole-genome joint mRNA  and miRNA pro-
ﬁle analysis from EV71-infected neuroblastoma cell SH-SY5Y.
They found that miR-1246 was speciﬁcally up-regulated by
EV71 in SH-SY5Y cells and could directly bound with the 3′
UTR of disk-large homolog 3 (DLG3) gene, which is associated
with neurological disorders.47 This result may partly explain
the neurological pathogenesis of EV71. We summarize the
functions and the target genes of the miRNAs involved in the
infection of EV71 in Table 1.
The  related  investigations  of  miRNAs  and  CVB3
CV including CVA and CVB mainly leads to herpangina and
human heart disease, especially viral myocarditis (VMC). Many
researches have focused on miRNAs related to CVB3 infection
because CVB3 is a common cause of myocarditis and dilated
cardiomyopathy. To evaluate the usefulness of miRNAs in the
pathogenesis of CVB3-induced VMC, Zhang et al. analyzed the
paired expression proﬁles of miRNAs and mRNAs on heart tis-
sues from CVB3-infected mice. They identiﬁed ﬁve distinctly
expressed miRNAs (miR-146a, miR-21, miR-374, miR-29a* and
miR-23a), which are involved in regulating several important
innate immune and antiviral pathways. This study showed
that miRNAs can regulate the pathogenesis of CVB3-induced
VMC.48
There are two miRNAs which can directly regulate the
replication of CVB3 by targeting the viral sequence. By using
RNAhybrid 2.2 and miRanda 3.2a software, Linlin Wang et al.
showed that there is a putative miR-342-5p target (nt 4989–nt
5015) in the 2C-coding region of CVB3. The experiment in vitro
and a moderate miR-342-5p abundance in CVB infected-Balb/c 1 5;1  9(5):510–516
mice validated that miR-342-5p can inhibit CVB3 replica-
tion by targeting its 2C-coding region.49 Soon after, this
group reported that miR-10a* can signiﬁcantly augment the
biosynthesis and replication of CVB3 151 by targeting its
nt6918–nt6941 sequence of the 3D-coding region. This article
shows that 152 miRNAs could up-regulate the expression of
the target genes.50
There are also many  miRNAs which can indirectly regulate
the replication of CVB3 through mediator. Zinc ﬁnger protein
(ZFP)-148, as a transcription factor, can regulate expression
of many  cell cycle regulatory genes and act as antiviral
agents for many  viruses. CVB3 infection up-regulated miR-203
through the activation of PKC/AP-1 cascade. Then, miR-203
up-regulated CVB3 replication through targeting ZFP-148.51
MiR-155 is reduced by inﬁltrating inﬂammatory macrophages
and T lymphocytes of both human and mice.52–54 MiRNA-155,
-146b, and -21 were consistently and signiﬁcantly upregu-
lated during VMC  both in mice and human. Inhibition of
miR-155 by LNA-Anti-miR in vivo caused cardiac injury and
dysfunction, decreased T lymphocyte activation during acute
myocarditis because miR-155 can target PU.1 (an inhibitor of
dendritic cell antigen presentation to T cells). It is showed
miR-155 is an adverse mediator of cardiac immune activa-
tion after CVB3-induced VMC. In vivo inhibition of miRNA-155
after CVB3 infection attenuates myocardial inﬂammation and
necrosis, so miRNA-155 can serve as a novel therapeutic
target for VMC.53 CVB3-induced miR-126 regulated CVB3 repli-
cation through two signal pathways, cross-talk of ERK1/2
and Wnt/-catenin pathways. By transfecting miRNA mimics
and inhibitors, it is suggested that miR-126 can regulate the
ERK1/2 signaling pathways by targeting EVH1 domain contain-
ing 1 (SPRED1). Besides, MiR-126 can regulate Wnt/-catenin
pathways by targeting lipoprotein receptor-related protein 6
(LRP6) and Wnt-responsive Cdc42 homolog 1(WRCh1), which
enhanced viral cytopathogenicity. In short, miR-126 promotes
CVB3 replication through mediating cross-talk of ERK1/2 and
Wnt/-catenin signal pathways by aiming at three speciﬁc tar-
gets: SPRED1, LRP6, and WRCH1.55 In the mouse model of
CVB3-infected VMC, miR-1 measured by real-time PCR was
upregulated upon CVB3 infection and its target gene Con-
nexin 43 (Cx43) measured by western blotting was signiﬁcantly
down-regulated. MiR-1 plays an important role in the patho-
physiology of VMC and interferes with cardiac function by
targeting Cx43, the main protein forming gap-junction chan-
nels in ventricular myocardium.56
Interestingly, there are several studies about miRNA-21
involved in CVB3 infection. In CVB3 induced myocarditis, the
expression of miR-21 was signiﬁcantly decreased, while pro-
grammed cell death 4 (PDCD4) was increased. Further research
showed that miR-21 alleviated CVB3-induced myocarditis and
repressed myocardial apoptosis by targeting PDCD4.57 MiR-
21 and miR-146b were upregulated in CVB3-infected VMC.
Silencing of miR-21 and miR-146b can decrease the expression
levels of Th17 and RORt and result in less-severe dam-
age. Further research showed that miR-21 and miR-146b can
regulate pathogenesis of murine VMC by regulating TH-17
differentiation through targeting RORt, TH-17 transcription
factor.58 CVB3-upregulated miR-21 can trigger heart muscle
cell damage by disrupting cardiomyocyte interactions. MiR-21
suppressed the levels of components in cell–cell interactions
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Table 1 – MiRNAs involved in EV71infection.
miRNAs Function Target Ref.
miR-296-5p Repression of viral replication EV71 VP3 and VP1-coding region 37
miR-23b Repression of viral replication EV71 3′ UTR 38
miR373 and miR542-5p Repression of viral replication EV71 5′ UTR 39
miRNA-548 Enhancement of replication of EV71 and VSV IFN-1  41
miR-146a Enhancement of viral pathogenesis IRAK1 and TRAF6 42
miR-526a Repression of viral replication CYLD 43
miR-146a and miR-370 Enhancement of EV71-induced cell apoptosis SOS1and GADD45  44
miR-141 Enhancement of EV propagation eIF4E 45
miR-27a Repression of viral replication EGFR 46
miR-1246 Contribution to the neurological pathogenesis DLG3 47
Table 2 – MiRNAs involved in CVB3infection.
miRNA Function Target Ref.
miR-146a, miR-21, miR-374, miR-29a*, miR-23a Regulation of pathogenesis of CVB3-Induced VMC Unknown 48
miR-342-5p Repression of CVB3 replication CVB3 2C-coding region 49
miR-10a* Enhancement of viral replication CVB3 3D-coding region 50
MiR-203 Enhancement of viral replication ZFP-148 51
MiR-155 Enhancement of myocardial inﬂammation response PU.1 53
miR-126 Promotion of viral replication SPRED1, LRP6, and WRCH1 55
miR-1 Interference of cardiac function Cx43 56
miR-21 Alleviation of CVB3-induced myocarditis PDCD4 57
miR-21 and miR-146b Regulation of viral pathogenesis ROPt  58
miR-21 Enhancement of viral pathogenesis YOD1 and VCL 59
miR-21 Enhancement of viral pathogenesis SPRY1 60
miRNA Veriﬁed functions of the miRNA Veriﬁed targets Ref.
miR-342-5p Repression of viral replication CVB3 2C-coding region 38
miR-10a* Enhancement of viral replication CVB3 3D-coding region 39
MiR-203 Enhancement of viral replication ZFP-148 40
MiR-155 Enhancement of myocardial inﬂammation response PU.1 42
miR-126 Promotion of viral replication SPRED1, LRP6, and WRCH1 genes 44
miR-1 Involved in viral myocarditis Cx43 45
miR-21 Alleviation of CVB3-induced myocarditis PDCD4 46
miR-21 and miR-124b Regulation of viral pathogenesis ROPt  47
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hrough targeting YOD1 and vinculin (VCL), which are two
omponents related to the regulation of cell–cell connections
nd cardiac function. The miR-21 expression during CVB3
nfection may contribute to the pathogenesis of VMC and
he inhibition of miR-21 can reduce host injury.59 MiR-21 was
igniﬁcantly upregulated in cardiac myocytes from VMC and
ilated cardiomyopathy (DCM) compared with control sam-
les. By Using bioinformatics analysis, they predicted miR-21
ould bind to 3′ UTR of homolog 1 (SPRY1). Further study in vitro
evealed that the overexpression of miR-21 was associated
ith a decrease in SPRY1 protein expression. These results
uggest that miR-21 may contribute to the pathogenesis of
MC  to DCM by targeting SPRY1.60 At the same time, miRNA-
1 was also related with other viruses by targeting a different
ene. For example, miRNA-21 was correlated with herpes sim-
lex virus (HSV)-induced Behc¸et’s Disease in patients and in
ouse model.61 Moreover, one of the HBV proteins, HBx can
nduce miRNA-21 expression in HBV-induced hepatocellular
arcinoma. Then, HBV infection enhances cell proliferation
ia HBx-induced miRNA-21 by targeting programmed cell
eath protein4 (PDCD4) and phosphatase and tensin homo-
ogue (PTEN).62 We  summarize the functions and the targetYOD1 and VCL 48
SPRY1 49
genes of the miRNAs involved in the infection of CVB3 in
Table 2.
The  related  investigations  of  miRNAs  and  other
EV
There have been many  recent reports about miRNAs related
to EV71 and CVB3, including about miRNAs other EV, such
as PV and HRV. The expression of miR-141 is upregulated in
cells infected with PV3 and CVB3, besides EV71.45 MiR-141 can
shut down host protein synthesis via mediating elF4E in PV3
and CVB3 infected cells, because eIF4E is the cap-dependent
translation initiation factor for shutting off host protein
synthesis.34 The replication of HRV is regulated by miRNAs
as decrease of mature miRNAs reduced by DICER knock-
down increases of HRV-1B replication in human bronchial
epithelial cells. Speciﬁc miRNAs binding to viral RNA dur-
ing HRV infection is demonstrated by co-immunoprecipitate
test with argonaute 2 protein. Finally, out of this group of
miRNAs, miR-128 and miR-155, under-expressed in the asth-
matic epithelium, can affect HRV-1B replication.63 Innate
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immune responses can restrict viral replication and innate
immune receptors, including toll-like receptor and retinoic
acid inducible gene I (RIG-I)-like receptor (RLR), which activate
IFN system. By using a microarray, several special miR-
NAs were found to be regulated by RLR signaling. One of
these RLR-inducible miRNAs, miR-23b, targets very low den-
sity lipoprotein receptor (VLDLR) and LDLR-related protein 5
(LRP5). Overexpression of miR-23b and anti-miR-23b resulted
in down-and up-regulated production of RV1B, respectively.
It has been shown that RIG-I signaling results in inhibition
of HRV1B infection because RIG-I-inducible miR-23 targets
VLDLR, a receptor for viral entry into the cell.64
Conclusions
Emerging evidence has demonstrated that miRNAs play a
key role in interaction network between the EV and host. EV
infections can change the expression of miRNAs in the cell.
Therefore, miRNAs affect enteroviral replication and patho-
genesis. Some miRNAs can regulate the expression of EV
gene directly; some miRNAs can regulate EV replication indi-
rectly by targeting a mediator. When miRNAs directly act on
enterovirus, miRNAs can combine with the 3′UTR, 5′UTR, VP1,
VP3, 2C-coding region, 3D-coding region of EV to promote
or suppress EV replication. When miRNAs indirectly interact
with EV, miRNAs can play a regulatory role on virus through
IFN, ZFP-148, or some other immune signaling pathways and
so on. In conclusion, there are a variety of complex regulated
relationship between miRNAs and EV, and miRNAs hold an
important biological role in enteroviral infection.
Although many  miRNAs are involved in the regulation of
enteroviral infection, there is still incomplete understanding
about this regulatory network. Based on the above review, miR-
NAs can bind to some regions of EV such as 3′UTR, 5′UTR,
VP1, VP3, 2C-coding region, 3D-coding region. Are there some
other EV targets of miRNAs? Although many  studies have
been reported about the process of interaction between miR-
NAs and EV71, CVB3, researches about miRNAs and other EV
are still limited and more  researches are needed. In addition,
future studies are required to explore the precise mechanism
by which miRNAs interfere in enteroviral infection in order
to increase our understanding of the interactions between
EV and miRNA. For example, EV71 can cause HFMD and lead
to the development of severe neurological diseases. However,
the involvement of miRNAs during the development of severe
neurological diseases is still unclear.
Currently, more  and more  miRNAs have great potential
usefulness to serve as biomarkers for the diagnosis of differ-
ent diseases, such as cardiovascular disease,65 glioblastoma,66
and so on. Five miRNAs (miR-197, miR-629, miR-363, miR-
132 and miR-122) could distinguish varicella patients from
healthy controls and from patients with Bordetella pertussis,
measles virus and EV.67 Importantly, miRNAs have a poten-
tial therapeutic role; SPC3649, a target of miR-122, is the ﬁrst
miRNAs-related drug to be tested in humans with hepatitis
C.68 This discovery open up the possibility to develop miRNAs-
related drugs to tackle enteroviral diseases. Future research is
warranted to explore the regulatory network of the miRNAs
1 1 5;1  9(5):510–516
and enterovirus, in order to explore miRNAs in the diagnosis
and treatment of enteroviral infection.
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